Lv11
60 积分 2023-08-18 加入
DLL3 draws two antibody–drug conjugate deals
7小时前
待确认
Unlocking the potential of bispecific ADCs for targeted cancer therapy
5个月前
已完结
Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
1年前
已完结
The hidden side of PD-L1
1年前
已完结
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy
1年前
已完结
In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy
1年前
已完结
Discoidin Domain Receptor 2: A New Target in Cancer
1年前
已完结
The effects of N-glycosylation sites and the N-terminal region on the biological function of [beta] 1, 3-N-acetylglucosaminyltransferase 2 and its secretion
1年前
已完结
皖公网安备34019202002308
